IGF2BP2 and dilated cardiomyopathy: Heart-specific overexpression of the RNA binding protein IGF2BP2 leads to dilated cardiomyopathy (DCM) and death in mice that can be rescued if downregulated in time, suggesting that IGF2BP2 could be a target for therapeutic intervention in DCM.